Skip to main content


Erratum: Longitudinal Study of Chronic Kidney Disease Progression and Associated Costs

Authored by

Ladan Golestaneh, MD, MS1; Paula J Alvarez, RPh, MPH, MBA2; Nancy L Reaven, MA3; Susan E Funk, MBA, FACHE3; Karen J McGaughey, PhD4; Alain Romero, PharmD, PhD2; Macaulay Onuigbo, MD, MSc, MBA5-7


1Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

2Relyspa Inc., a Vifor Pharma Group Company, Redwood City, CA

3Strategic Health Resources, La Cañada, CA

4California Polytechnic State University, San Luis Obispo, CA

5Mayo Clinic, Rochester, MN

6Mayo Clinic Health System, Eau Claire, WI

7University of Wisconsin MBA Consortium, Eau Claire, WI


J Clin Pathways. 2017;3(9):40-48.

The article,Longitudinal Study of Chronic Kidney Disease Progression and Associated Costs,” appearing in the November 2017 issue of Journal of Clinical Pathways, was updated for minor editorial additions and formatting changes, per request of the authors. The updated version of the article can been viewed online

Back to Top